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ABSTRACT 
Fibrotic lung diseases increase with age. Previously 
we determined that senescence increases tissue ex- 
pression of fibronectin EDA (Fn-EDA) and decreases 
fibroblast expression of Thy-1, and that fibrocytes 
contribute to fibrosis following bleomycin-induced 
lung injury in mice. In this study we hypothesized 
that fibroblasts lacking Thy-1 expression produce an 
extracellular matrix that promotes fibrocyte retention 
and myofibroblast transdifferentiation, thereby pro- 
moting fibrogenesis. Young and old mice were treated 
with bleomycin intratracheally; fibrocytes in the bone 
marrow, blood, and lungs were quantified, and lung 
fibroblast Thy-1 expression was assessed. Bone mar- 
rowderived fibrocytes were cultured on matrices de- 
rived from Thy-1(+) or Thy-1(−) fibroblasts ± the 
pro-fibrotic cytokine TGFβ1. Older mice had more 
fibrocytes in their bone marrows at baseline and 
more fibrocytes in their lungs following bleomycin 
treatment. In parallel, lung fibroblasts in older mice 
had lower expression of Thy-1 at baseline that in-
creased transiently 7 days after bleomycin treatment 
but then rapidly waned such that 14 days after bleo- 
mycin treatment Thy-1 expression was again mar- 
kedly lower. Fibrocytes cultured on matrices derived 
from Thy-1(−) fibroblasts + TGFβ1 had increased 
gene expression for collagen type 1, fibronectin, 
Fn-EDA, and α-smooth muscle actin. In parallel, 
whereas the matrices derived from Thy-1(−) fibrob- 
lasts stimulated phosphorylation of Akt in cultured 
fibrocytes, the matrices derived from Thy-1(+) fibro- 
blasts induced apoptosis. These findings suggest that 
senescence increases fibrocyte recruitment to the lung 
following injury and that loss of Thy-1 expression by 
lung fibroblasts promotes fibrocyte retention and 
myofibroblast transdifferentiation that renders the 
“aging lung” susceptible to fibrosis.  
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1. INTRODUCTION 
Idiopathic Pulmonary Fibrosis (IPF) is a devastating pro- 
gressive lung disease with an average survival of only 3 
to 5 years [1]. The mechanisms underlying the initiation- 
nand progression of IPF are poorly understood and cur- 
rently there are no effective treatments [2]. Aging or “se- 
nescence” is associated with increased susceptibility to 
injury and fibrosis [3-5]. However, there is little known 
about how senescence predisposes the lung to ineffective 
repair and increased fibrosis after injury.  
Several factors have been linked to pathological lung 
fibrogenesis including circulating bone marrow-derived 
fibroblast progenitor cells, known as fibrocytes [6-8]. Fi- 
brocytes are bone marrow-derived fibroblast progenitor 
cells characterized by their expression of both stromal 
markers (i.e. collagen types I and III and vimentin) and 
hematopoietic markers (i.e. CD45) [9]. Several studies, 
both in experimental animal model and humans, demon- 
strate that fibrocytes are recruited (via the CXCR4 axis) 
to sites of tissue injury including the lung where they *Corresponding author. 
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contribute to pathological fibrosis [9,10]. Once recruited 
to injured tissues, fibrocytes may transdifferentiate into 
myofibroblasts and this speculation is supported by the 
fact that fibrocytes can be induced to differentiate into 
myofibroblasts by exposure to TGFβ1 in vitro [11]. 
However, the precise fate of fibrocytes in the lung has 
not been well elucidated, and it is unclear why fibrocytes 
promote pathological fibrosis in certain circumstances 
but not in others and why senescent lungs are more prone 
to develop fibrosis. 
Under normal conditions within the lung, the extra- 
cellular matrix (ECM) is derived primarily from residen- 
tial lung fibroblasts that are a heterogeneous population 
expressing different surface markers and displaying dif- 
ferent functional characteristics. One of the most exten- 
sively studied surface markers of fibroblast heterogeneity 
is Thy-1 [12]. Several studies showed that Thy-1(+) fi- 
broblasts differ from Thy-1(−) fibroblasts in many ways 
including the relative compositions of the ECM they 
produce [13,14]. Lack of Thy-1 expression is associated 
with increased TGFβ1 activation [15,16] and relatively 
greater fibrotic responses to bleomycin-induced lung in- 
jury in mice [12]. We previously determined that senes- 
cent lungs contain more fibroblasts lacking Thy-1 ex- 
pression (both a decrease in the number of cells with 
Thy-1 expression and a reduction in Thy-1 expression 
per cell) and these lungs also express more TGFβ1 at 
baseline [17].  
Accordingly, we hypothesized that lung senescence is 
associated with a progressive loss of lung fibroblast 
Thy-1 expression, and that these fibroblasts induce the 
production of a “pro-fibrotic” matrix that promotes fi-
brocyte trafficking and retention in response to injury 
where they undergo myofibroblast transdifferentiation 
and contribute to subsequent lung fibrosis. To test this 
hypothesis, we compared lung fibroblast Thy-1 expres- 
sion and fibrocyte trafficking to the lung in young and 
old mice following bleomycin-induced lung injury.  
2. MATERIALS AND METHODS 
2.1. Animals 
Young (3 month) and old (24 month) C57BL/6 mice 
were utilized. All studies were approved by the Institu- 
tional Animal Care and Use Committee (IACUC) at 
Emory University and conformed to institutional stan- 
dards for the humane treatment of laboratory animals. 
2.2. Bleomycin-Induced Lung Injury 
Bleomycin-induced lung injury was performed as pre- 
viously described [17]. Mice received either bleomycin 
(2.5 units/kg) in phosphate-bufferedsaline (PBS) or ve- 
hicle (PBS) alone intratracheally. Mice were euthanized 
at 7 and 14 days following injury; lungs, blood and bone 
marrow were harvested for analyses.  
2.3. Lung Fibroblast Isolation, Characterization  
and Thy-1 Subpopulation Purification 
Primary lung fibroblasts (PLFs) were harvested from all 
treatment groups as previously described [17]. PLFs 
(passage 1) were harvested and surface stained with anti- 
mouse Thy-1 conjugated with Phycoerythrin (PE) fluo- 
rescent and subjected to flow cytometry analysis for 
Thy-1 expression or sorting using Aria. Sorted cells were 
then cultured and expanded in fibroblast culture medium.  
2.4. Analysis of Fibrocytes in Peripheral Blood, 
Bone Marrow and Lung 
Cells from blood, bone marrow and lung were surface 
stained with PerCP-conjugated anti-mouse-CD45 and 
Phycoerythrin (PE)-conjugated anti-mouse CXCR4, per- 
meabilized and stained with a rabbit anti-collagen I anti- 
body followed by FITC-conjugated goat anti-rabbit IgG 
secondary antibody. Samples were analyzed on a FACS- 
Calibur and data were analyzed using the FlowJo soft- 
ware. 
2.5. Fibrocytes Isolation and Characterization 
Total adherent bone marrow cells were obtained as pre- 
viously described [18]. Cells were purified using the 
MAC system to eliminate CD3e, CD14, CD19 and Ly6G 
positive cells as well as CD45 negative cells. Purified 
cells were utilized for experiment or characterization 
(described below). For characterization, cells obtained 
from magnetic cell separation were stained with CD45 
and Col-1 and analyzed by flow cytometry as described 
above (Figure 1). Our purity of the isolated (Col1 + 
CD45+) was approximately 44.5%. 
2.6. Fibrocyte Differentiation on Fibroblast  
Subpopulation-Derived Matrix 
Thy-1(+) or Thy-1(−) fibroblasts were cultured in me- 
dium containing 10% of fibronectin-depleted serum for 
96 hours. Fibroblasts were lysed using sterile DOC lysis 
buffer [19] leaving insoluble assembled ECM on the 
culture surface. Following multiple washes with PBS, 
visualization with microscopy was performed to assess 
for any left over fibroblasts. Fibrocytes were cultured 
atop these surfaces. At 24 hours after initial plating, cells 
were incubated with 2 ng/mL of recombinant TGFβ1. 
Cells were harvested for analysis of phospho-Akt and 
total Akt expression (at 2 hours) and for mRNA expres- 
sion (at 24 hours) and for α-SMA expression, and ex- 
pression of cleaved caspase 3, TUNEL and Annexin V 
staining (at 72 hours).   
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Figure 1. Fibrocyte isolation and purification. Fibrocytes were isolated from adherent cells 
cultured from total bone marrow. Cells were negatively selected for CD3e, CD14, CD19 and 
Ly6G and positively selected for CD45 by magnetic bead separation. Enriched fibrocytes 
were stained for CD45 and collagen type I for flow cytometry analysis. (A) shows a repre-
sentative histogram of collagen type I staining in comparison to unstained and isotype control 
staining. (B) shows a representative histogram of CD45 staining in comparison to positive 
control (lymphocytes) and unstained cells. (C) shows a density plot of CD45 and Collagen 
type I staining, which show approximately 44.5% of cells are collagen type I+ and CD45+. 
 
2.7. Messenger RNA Expression Analysis 
Messenger RNA from in vitro experiment was isolated, 
first-strand cDNA was synthesized as previously de- 
scribed [20]. Quantitative polymerase chain reaction (PCR) 
was performed with primers set for 18s, fibronectin (FN), 
FN EDA, collagen type I, and α-smooth muscle actin 
(α-SMA) and analyzed as previously described [17,20].  
2.8. Protein Isolation and Analysis 
Protein from cultured fibrocytes was harvested and West- 
ern Immunoblot was performed as previously described 
[17]. Blots were incubated with primary antibodies as 
follows; rabbit anti-mouse phospho-Akt, pan-Akt or 
cleaved caspase 3 at 1:1000, then followed by an appro- 
priate secondaryantibody and visualized via enzyme- 
linked chemiluminescenceusing the SuperSignal West 
Pico kit [17]. 
2.9. Immunofluorescent Staining for α-SMA 
Cells were fixed and permeabilized and incubated with 
primary antibody; rabbit anti-mouse α-SMA at 1:200 at 
4˚C overnight. Slides were incubated with a secondary 
antibody; goat anti-rabbit 488 at 1:500; DAPI nuclear 
stain was applied and visualized using the Olympus 
BX51. Cells were counted and the percentage of cells 
that stained positive for α-SMA was calculated from 5 
random 20× magnification fields. 
2.10. Analysis for Apoptosis by Terminal  
Deoxynucleotidyl Transferase dUTP Nick 
End Labeling (TUNEL) Assay and Annexin  
V Staining 
TUNEL assay and Annexin V staining were performed 
using the in situ cell death detection kit, POD and An- 
nexin V-FITC Fluorescence Microscopy Kit according to 
manufacturer’s protocol. Slides were visualized using the 
Olympus BX51. Cells were counted and the percentage 
of cells that stained positive for TUNEL or Annexin V 
was calculated from 5 random 20× magnification fields. 
2.11. Statistical Analyses 
One-way ANOVA was usedfor comparisons among 
groups, and post-test analysis using Bonferroni’s method 
performed if statistical significance was reached. Signif- 
icant differences were accepted at a P level of <0.05. 
3. RESULTS 
3.1. Senescent Bone Marrow Contains Higher 
Number of Fibrocytes at Baseline and  
Senescent Lungs Retain More Fibrocytes  
Following Bleomycin-Induced Injury 
We first quantified the percentages of fibrocytes (CD45+, 
CXCR4+, Collagen type 1 + cells) in the bone marrow, 
peripheral blood and the lung in mice 14 days following 
sham treatment and compared these to the percentages of 
fibrocytes in these respective compartments in mice 7 
and 14 days following bleomycin treatment. As shown in 
Figure 2 (Figure 2A shows representative flow cytome- 
try histograms and Figure 2B shows the summary data), 
sham-treated old mice had a significantly higher percen- 
tage of fibrocytes in their bone marrow than sham- 
treated young mice; in contrast, there were no apparent 
differences in the percentage of fibrocytes in the peri- 
pheral blood or the lungs of sham-treated older or young- 
er mice. By comparison, 7 days following bleomycin- 
induced lung injury there was a significant decrease in   
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Figure 2. Fibrocyte trafficking into the peripheral blood and to the lungs is increased in old mice following bleomycin-induced 
lung injury. (A) shows representative scatter plots of CD45+ cells, gated for CXCR4 and collagen type I (fibrocytes) in the bone 
marrow, peripheral blood and the lung. (B) shows the percentages of fibrocytes in the bone marrow, peripheral blood, and the lungs 
of young mice (3 months old, open bars) and old mice (24 months old, closed bars) at 14 days following sham treatment with 
phosphate-buffered saline (PBS), and at 7 days and 14 days following bleomycin treatment. N = 5 - 6 in each group. *P < 0.05 in-
creased compared to young sham-treated group. **P < 0.05 decreased compared to young bleomycin-treated mice at 14 days. 
 
the percentage of fibrocytes in the bone marrows of old 
mice and a concomitant and significant increase in the 
percentage of fibrocytes in their peripheral blood and 
lungs, whereas there were no significant differences in 
any of these compartments in young mice 7 days follow- 
ing bleomycin-induced lung injury. In parallel, the per- 
centage of fibrocytes in the lung remained elevated in old 
mice 14 days following bleomycin-induced lung injury, 
whereas there was still no increase in the percentage of 
fibrocytes in the lungs of young mice. Interestingly, 
young mice quite dramatically increased the percentage 
of fibrocytes in their bone marrow compartment 14 days 
following bleomycin-induced lung injury but not in their 
peripheral blood or lungs.  
3.2. Bleomycin-Induced Lung Injury Is  
Associated with an Increase in Thy-1  
Expression by Lung Fibroblasts in Both  
Young and Old Mice  
We previously showed that senescence is associated with 
a decrease in the expression of Thy-1 protein by lung 
fibroblasts in mice [17]. In parallel, it has been shown 
that inflammation alters endothelial cell Thy-1 expres- 
sion [21]. We hypothesized that senescence could alter 
the response to injury by the lung fibroblast. Therefore, 
we next examined Thy-1 protein expression by lung fi- 
broblasts isolated from young and old mice 14 days after 
sham treatment and compared this to Thy-1 protein ex- 
pression by lung fibroblasts isolated from young and old 
mice 7 and 14 days following bleomycin-induced lung 
injury. As shown in Figure 3, fibroblasts derived from 
sham-treated old mice had significantly less expression 
of Thy-1 than fibroblasts from sham-treated young mice. 
Interestingly, lung fibroblast expression of Thy-1 in- 
creased significantly in both old and young mice 7 days 
following bleomycin-induced lung injury, but by 14 days 
had decreased back to levels seen in lung fibroblasts 
from sham-treated mice young and old mice, respectively.  
3.3. The Extracellular Matrix (ECM) Derived 
from Thy-1(−) Fibroblasts Promotes  
Fibrocyte to Myofibroblast  
Transdifferentiation in the Presence of 
TGFβ1 
As shown in Figure 1, only the lungs of old mice had an 
increase in the percentage of fibrocytes following bleo- 
mycin-induced lung injury, and this increase was sus- 
tained for at least 14 days. This finding, coupled with the 
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Figure 3. Lung fibroblasts from both young and old mice 
increase Thy-1 expression in response to bleomycin-in- 
duced lung injury. Primary lung fibroblasts were isolated 
from the lungs of young (3 months old, open bars) and old 
(24 months old, closed bars) mice at 14 days following 
sham treatment with phosphate-buffered saline (PBS), and 
at 7 days and 14 days following bleomycin treatment. Iso-
lated fibroblasts were analyzed by flow cytometry for 
Thy-1 expression, as represented by mean fluorescence 
intensity (MFI). N = 3-6 mice per group. Data are 
represented as mean ± SEM. *P < 0.05 decreased com-
pared to young sham-treated group. **P < 0.05 increased 
compared to young sham-treated group. 
 
observation that lung fibroblasts from old mice expressed 
less Thy-1, led us to hypothesize that the extracellular 
matrix (ECM) derived from Thy-1(−) fibroblasts pro- 
motes fibrocyte recruitment and myofibroblast transdif- 
ferentiation. To test this hypothesis, we next compared 
markers of differentiation in fibrocytes cultured on the 
ECM produced by Thy-1(+) and Thy-1(−) fibroblasts in 
the presence or absence of recombinant TGFβ1. As 
shown in Figures 4A and B, there were no significant 
differences in Col1A1 or α-SMA mRNA expression be- 
tween fibrocytes cultured on ECM derived from Thy-1(+) 
or Thy-1(−) fibroblasts in the absence of TGFβ1. In pa-
rallel, there were no significant differences in α-SMA 
protein expression between fibrocytes cultured on ECM 
derived from Thy-1(+) or Thy-1(−) fibroblasts in the ab- 
sence of TGFβ1 (Figure 4C). However, in the presence 
of TGFβ1, fibrocytes cultured on ECM derived from 
Thy-1(−) lung fibroblasts significantly expressed their 
expression of Col1A1 and α-SMA mRNA (Figures 4A 
and B) and α-SMA protein expression (Figure 4C) as 
compared to fibrocytes cultured on ECM derived from 
Thy-1(+) lung fibroblasts. Interestingly, if anything the 
ECM derived from Thy-1(+) fibroblasts appeared to 
suppress fibrocyte α-SMA mRNA expression even in the 
presence of TGFβ1 (Figure 4B).  
3.4. The Extracellular Matrix (ECM) Derived 
from Thy-1(-) Fibroblasts Stimulates  
Fibrocytes to Express Fibronectin-EDA in 
the Presence of TGFβ1 
We previously showed that senescent lungs expressed 
higher levels of fibronectin-EDA mRNA at baseline and 
in response to bleomycin-induced injury [17]. We hy- 
pothesized that fibrocytes recruited to the lung in re- 
sponse to injury contribute to this increased fibronectin- 
EDA expression in senescent lungs via interactions with 
senescent ECM. To examine this, we compared fibronec- 
tin and fibronectin-EDA expression by fibrocytes cul- 
tured on ECM derived from Thy-1(+) or Thy-1(−) lung 
fibroblasts in the presence or absence of TGFβ1. As pre- 
dicted, TGFβ1 stimulated fibronectin and fibronectin- 
EDA mRNA expression by fibrocytes in all groups (Fig- 
ure 5). However, there was a significant increase in 
mRNA expression of both fibronectin (Figure 5A) and 
fibronectin-EDA (Figure 5B) when fibrocytes were cul- 
tured on an ECM derived from Thy-1(−) lung fibroblasts 
in the presence of TGFβ1. Interestingly and unexpectedly, 
in the absence of TGFβ1 the ECM derived from Thy-1(−) 
lung fibroblasts seemed to suppress fibrocytes fibronec-
tin-EDA mRNA expression as compared to Thy-1(+) 
matrix without TGFβ1 group (Figure 5B), suggesting 
that the effects of TGFβ1 and Thy-1(−) fibroblast-de- 
rived ECM on fibrocyte expression of fibronectin-EDA 
are not simply additive but rather are synergistic.  
3.5. The Extracellular Matrix (ECM) Derived 
from Thy-1(−) Lung Fibroblasts Stimulates 
Akt Phosphorylation, Which Is Indicative of 
Cell Survival 
To examine how the ECM derived from Thy-1(+) and 
Thy-1(−) lung fibroblasts affects cell survival pathways 
in fibrocytes, we compared the expression of phospho- 
Akt and total Akt from fibrocytes cultured on these ma- 
trices. Some cells were stimulated with TGFβ1 (2 ng/ml) 
for 2 hours prior to harvesting for protein extraction and 
analysis. As shown in Figure 6, we determined that fi- 
brocytes cultured on an ECM derived from Thy-1(-) lung 
fibroblasts had increased phosphorylation of Akt (pAkt) 
following TGFβ1 stimulation at 2 hours when compared 
to fibrocytes cultured on an ECM derived from Thy-1(+) 
lung fibroblasts, which in fact did not express pAkt even 
when stimulated with TGFβ1. 
3.6. The Extracellular Matrix (ECM) Derived 
from Thy-1(+) Lung Fibroblasts Promotes 
Fibrocyte Apoptosis 
To examine the potential mechanisms by which the ECM 
derived from Thy-1(+) fibroblasts inhibits fibrocyte to 
myofibroblast transdifferentiation, we assessed fibrocyte 
apoptosis in response to culture on these matrices (by 
TUNEL assay and Annexin V). As shown in Figure 7, 
there was significant increase in TUNEL positive cells 
when fibrocytes were cultured on an ECM derived from 
Thy-1(+) lung fibroblasts, both in the presence and ab-  
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Figure 4. The extracellular matrix (ECM) derived from Thy-1(−) lung fibroblasts promotes 
fibrocyte-to-myofibroblast transdifferentiation in the presence of TGFβ1. Lung fibroblasts 
were isolated from young mice and sorted by FACS on a BD FACSAria cell sorter into 
Thy-1(+) and Thy-1(−) subpopulations. Samples with purity >90% were cultured in FN-dep- 
leted media. At 96 hours, cells were lysed to release endogenous extracellular matrix (ECM). 
Bone marrow-derived fibrocytes were cultured on a control surface (plastic) or on an ECM 
derived from either Thy-1(+) or Thy-1(−) fibroblasts in the presence or absence of TGFβ1 (2 
ng/ml). At 24 hours after TGFβ1 treatment, cells were harvested for (A) collagen type I and 
(B) α-SMA mRNA expression as determined by real time RT-PCR. (C) At 72 hours, cells 
were harvested and immunostained for α-SMA protein expression and evaluated by confocal 
microscopy (upper inset). Original magnification 400x, scale bar = 50 µm.Summary results 
in the lower inset of panel C are the percentage of cells positive for α-SMA over 5 random 
200× magnification fields per slide and are represented as mean ± SEM. *P < 0.05 increased 
compared to fibrocyte control group without TGFβ1 treatment. #P < 0.05 increased compared 
to fibrocyte control group with TGFβ1 treatment. 
 
 
Figure 5. The extracellular matrix (ECM) derived from Thy-1(−) fibroblasts induces fibro-
nectin-EDA gene expression in the presence of TGFβ1. At 24 hours following TGFβ1 treat-
ment, cells were harvested and analyzed for (A) fibronectin (FN) and (B) fibronectin-EDA 
(FN-EDA) mRNA expression by real time RT-PCR. N = 3 mice per group. Data are 
represented as mean ± SEM. *P < 0.05 increased compared to fibrocyte control group without 
TGFβ1 treatment. **P < 0.05 decreased compared to fibrocyte control group without TGFβ1 
treatment. #P < 0.05 increased compared to fibrocyte control group with TGFβ1 treatment. 
 
sence of TGFβ1, when compared to fibrocytes culture on 
an ECM derived from Thy-1(−) lung fibroblasts (Figure 
7A), and these findings were supported by a similar in- 
crease in Annexin V staining (Figure 7B). As further 
evidence in support of these findings, we also determined 
that fibrocytes cultured on an ECM derived from 
Thy-1(+) lung fibroblasts showed a trend toward an in- 
crease in cleaved caspase 3 protein expression as com-  
V. Sueblinvong et al. / Advances in Bioscience and Biotechnology 5 (2014) 19-30 
Copyright © 2014 SciRes.                                                                       OPEN ACCESS 
25 
 
Cnt = Control, Pos = matrix derived from Thy-1(+) fi-
broblasts, and Neg = matrix derived from Thy-1(−) fi-
broblasts. N = 3 mice per group. Data are represented as 
mean ± SEM.  *P <0.05 increased compared to fibro-
cyte control group without TGFβ1 treatment. 
Figure 6. The extracellular matrix (ECM) de-
rived from Thy-1(−) lung fibroblasts stimulates 
fibrocyte Akt phosphorylation. At 2 hours fol-
lowing TGFβ1 (2 ng/ml) treatment, cells were 
harvested for analysis of Akt phosphorylation 
by western blot. Positive and negative controls 
were cell extracts purchased from Cell Signal-
ing. Upper inset shows representative western 
blots for total Akt and phospho-Akt expression. 
Lower inset shows densitometric analyses of 
phospho-Akt (pAkt) expression in relation to 
total Akt.  
 
pared to other conditions regardless of TGFβ1 treatment 
(Figure 7C).  
4. DISCUSSION 
In this study, we determined that senescent mice had 
more fibrocytes in their bone marrow, but comparable 
numbers of fibrocytes in the lung, when compared to 
young mice. However, following bleomycin-induced 
lung injury, senescent mice had more circulating fibro- 
cytes and evidence for greater fibrocyte recruitment and/ 
or retention in the lung as compared to the younger mice, 
and this increase in the number of lung fibrocytes per- 
sisted up to 14 days after the injury. Consistent with our 
previous finding that lung fibroblasts isolated from se- 
nescent mice expressed less Thy-1 at baseline [17], we 
showed here that lung fibroblasts isolated from senescent 
mice expressed less Thy-1 at baseline and, despite a tran- 
sient increase in lung fibroblast Thy-1 expression 7 days 
following bleomycin treatment, this expression rapidly 
waned to baseline low levels by 14 days following acute 
lung injury, whereas lung fibroblasts from younger mice 
maintained their higher levels of Thy-1 expression. In-  
parallel, we determined that isolated bone marrow-de- 
rived fibrocytes cultured in vitro on the extracellular ma- 
trix (ECM) derived from Thy-1(−) lung fibroblasts, 
which comprise the majority of fibroblasts in the senes-
cent mouse lung, expressed more collagen type I mRNA, 
and more α-SMA mRNA and protein, in the presence of 
TGFβ1 as compared to fibrocytes cultured on plastic or 
on ECM derived from Thy-1(+) lung fibroblasts. Further, 
we found that ECM derived from Thy-1(−) lung fibrob- 
lasts induced phosphorylation of Akt, which is part of a 
cell survival pathway, and promoted myofibroblast trans- 
differentiation, whereas the matrix derived from Thy-1(+) 
lung fibroblasts induced fibrocyte apoptosis in the pres- 
ence of TGFβ1. Taken together, these studies provide 
novel evidence that Thy-1(−) fibroblasts, which represent 
the major lung fibroblast population in the lungs of old 
mice, produce a “pro-fibrotic” ECM that may promote 
fibrocyte retention and survival in the lung, as well as 
myofibroblast transdifferentiation, following injury and 
thereby render the senescent lung susceptible to fibrosis. 
These findings extend our previous studies in which we 
determined that senescent mice are more susceptible to 
lung fibrosis following bleomycin-induced injury [17]. 
Fibroblasts are normally present in the lung to help 
support the complex structure and function of the air- 
ways and their adjacent blood vessels. Following lung 
injury, the coordinated migration and proliferation of fi- 
broblasts, coupled with the provisional ECM they pro- 
duce, are essential steps for the development of granula- 
tion tissue, re-epithelization of injured airways, and the 
eventual removal of these activated fibroblasts [22]. 
Over the past decade, the precise origins of fibroblasts 
that have been implicated in fibrogenesis have been ex- 
amined. These include the migration of residential lung 
fibroblasts, the transformation or “transition” of epitheli- 
al cells in situ (epithelial-mesenchymal transition or 
EMT), and recruitment and retention of a circulating 
population of fibroblast progenitor cells or fibrocytes 
[22-24]. Several reports over the past decade have sug- 
gested that fibrocytes play an important role in fibroge- 
nesis of various tissues including the lung [7-9]. In clini- 
cal studies, fibrocytes have been shown to increase in  
numbers in the lungs of patients with pulmonary fibrosis, 
and the number of circulating fibrocytes was shown to 
correlate with the disease activity and mortality in these 
patients [8,24,25]. However, whether fibrocytes are 
simply a biomarker or in fact play a causal role in the 
pathogenesis of fibrotic lung diseases is unclear. In this 
study, we showed that senescent mice have more fibro- 
cytes (as determined by cells with CD45+ CXCR4 + 
Col1+) in their bone marrow as compared to young mice. 
In parallel, even though they have the same number of 
fibrocytes in the circulation and in the lung at baseline, 
following bleomycin-induced lung injury senescent mice  
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*P < 0.05 increased compared to fibrocyte control group without TGFβ1 treatment. 
Figure 7. The extracellular matrix (ECM) derived from Thy-1(+) positive lung fibroblasts promotes apoptosis pathways 
in fibrocytes. Cultured fibrocytes were harvested and analyzed for markers of apoptosis by (A) TUNEL assay, (B) An-
nexin V expression, and (C) cleaved Caspase 3 protein expression 72 hours after TGFβ1 treatment. The upper inset in (A) 
shows representative microscopic images of the TUNEL assay(200×, bar = 100 μM). The lower inset in (A) is a bar graph 
representation of the percentages of TUNEL positive cells from 5 random 200× magnification fields per slide. The upper 
inset in (B) shows representative microscopic images of Annexin V staining (200×, bar = 100 μM) and the lower inset is a 
bar graph representation of the percentages of Annexin V positive cells analyzed from 6 random 200x magnification 
fields per slide. White arrows = cells positive for Annexin V. The upper inset in (C) shows Caspase 3 protein expression 
by western blot and the lower inset is a bar graph showing relative Caspase 3 protein expression by densitometric analys-
es. Cnt = Control, Pos = matrix derived from Thy-1(+) fibroblasts, and Neg = matrix derived from Thy-1(−) fibroblasts. 
N = 3 mice per group. Data are represented as mean ± SEM.  
 
had significant increases in the percentages of both cir- culating fibrocytes and lung fibrocytes compared to 
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young mice. These findings suggest that there are as yet 
undefined factors in the senescent lung that promote fi- 
brocyte trafficking, retention, and/or survival in the lung 
following an acute injury. Based on our previous work as 
well as our findings in this new study, one intriguing 
candidate is the Thy-1(−) fibroblast that accumulates in 
the senescent lung.  
It has been known that the microenvironment can in- 
fluence cellular functions and behaviors [26-28]. For ex- 
ample, the stiffness or even contour of the culture surface 
can influence stem cell differentiation in vitro [29]. 
These microenvironments include other residential cells, 
soluble factors such as cytokines and chemokines, and 
the surrounding extracellular matrix [28]. Several factors 
have been shown to induce or promote lung fibrogenesis; 
these include TGFβ1, the EDA variant of fibronectin 
(Fn-EDA), and the relative shift toward a Thy-1(−) phe- 
notype in lung fibroblasts [12,22,30]. We previously 
showed that the senescent lung microenvironment is dif- 
ferent than that of the young lung, including the combi- 
nation described above (increased TGFβ1 and Fn-EDA 
expression coupled with a decrease in fibroblast Thy-1 
expression) [17]. We were particularly interested in 
Thy-1 expression because Thy-1(-) fibroblasts have been 
shown to be capable of activating TGFβ1 and Thy-1 null 
mice show increased fibrotic responses to bleomycin- 
induced lung injury as compared to wild type mice [12, 
15]. These previous findings suggest that phenotypic 
changes in fibroblasts associated with the down-regula- 
tion of Thy-1 expression might promote fibroprolifera- 
tion in the lung. This mechanism might be important in 
fibrotic lung diseases such as idiopathic pulmonary fi- 
brosis (IPF) since affected individuals show accumula- 
tion of Thy-1(−) fibroblasts in fibroblastic foci [31]. Pre- 
viously, we identified a significant decrease in Thy-1 
surface molecule expression by lung fibroblasts isolated 
from senescent mouse lungs [17].  
It has been previously shown that lung fibroblasts in- 
crease their Thy-1 expression in response to inflamma- 
tion [32,33]. We speculated that one of the mechanisms 
by which senescence increases fibrogenesis is by altering 
how the lung fibroblast responds to inflammation and 
injury. We were in fact somewhat surprised to find that 
there was in fact a comparable increase in Thy-1(+) lung 
fibroblasts following bleomycin-induced inflammation 
and injury in both young and old mice. These findings 
suggest that senescence may have not altered the initial 
lung fibroblast response to injury. However, we do not 
know whether there were any alterations in the function 
of these fibroblasts in the older mice, such as cytokine 
expression or ECM production, and by 14 days after 
acute lung injury this response had waned in the older 
mice. Clearly the transient increase (by recruitment and/ 
or phenotype switch) of a Thy-1(+) fibroblast subpopula- 
tion alone was insufficient to protect senescent lungs 
from an aberrant fibrotic response to bleomycin, and our 
results may reflect the importance of the baseline (i.e. 
“pre-injury”) ECM in effective lung repair following an 
acute injury. Specifically, the ECM derived from differ- 
ent subpopulations of lung fibroblasts appears to have a 
powerful influence on the behavior of bone marrow- 
derived fibrocytes that are recruited to the lung in re- 
sponse to an acute injury.  
As described above, the microenvironment (including 
the ECM, resident cells, and their protein/receptor ex- 
pression) influences cellular behavior. In this study we 
focused on the lung microenvironment and its interaction 
with recruited cells; specifically, fibrocytes and their 
possible role in aberrant repair and fibrotic response to 
injury in senescent lungs. We hypothesized that the age- 
related changes in the lung fibroblast phenotype altera- 
tion at baseline (particularly the loss of Thy-1 surface 
expression) is associated with the production of a “pro- 
fibrotic” matrix that in turn promotes the recruitment, 
retention, and transdifferentiation of fibrocytes, all lead- 
ing to an aberrant injury response and the development 
of fibrosis. To assess this, we cultured fibrocytes on ei- 
ther a control culture surface (cell culture coated com- 
mercial available plastic ware) or on the ECM derived 
from Thy-1(+) or Thy-1(−) lung fibroblasts in the pres- 
ence or absence of TGFβ1. Although the purity of fibro- 
cyte we used in this particular study was approximately 
44.5% and it was likely that the CD45+Col1- in the 
preparation were leukocytes, not mesenchymal stem cells; 
that could also differentiate into fibroblast or myofibrob- 
last in the right condition, which could alter the interpre- 
tation of this study. We found that without TGFβ1 stimu- 
lation, there was no detectable difference in collagen 
type I and α-SMA mRNA expression or in α-SMA pro- 
tein expression, which are the indicators of myofibrob- 
last transdifferentiation. There was also no difference in 
fibronectin mRNA expression. Interestingly, Thy-1(−)- 
derived matrix appeared to suppress Fibronectin-EDA 
mRNA expression in the absence of TGFβ1 as compared 
to other culture conditions. However, in the presence of 
TGFβ1, fibrocytes cultured on ECM derived from 
Thy-1(−) lung fibroblasts expressed more collagen type I, 
fibronectin, fibronectin-EDA and α-SMA mRNA and 
more α-SMA protein compared to fibrocytes cultured on 
an ECM derived from Thy1(+) lung fibroblasts. Taken 
together, these data suggest that the ECM derived from 
Thy-1(−) somehow interacts with TGFβ1 to promote fi- 
brocyte-to-myofibroblast transdifferentiation, whereas 
the ECM derived from Thy-1(+) fibroblasts does not. We 
further demonstrated that, in addition to the promoting 
fibrocyte-to-myofibroblast transdifferentiation in the 
presence of TGFβ1, the ECM derived from Thy-1(−) 
lung fibroblasts also promotes proliferation/survival pa-  
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thways in the fibrocyte as reflected by increased phos-
phorylation of Akt, which is one of the components in 
the cell survival pathway [34], whereas the Thy-1(+)- 
derived ECM promoted fibrocyte apoptosis, as reflected 
by an increase in TUNNEL and Annexin V positive cells 
and trend toward an increase in expression of cleaved 
caspase 3. Whether or not this stimulation of the Akt 
pathway is through TGFβ1 receptors or through integrin 
receptor-ECM interaction, and whether or not this sti-
mulation directly leads to fibrocyte to myofibroblast 
transdifferentiation, will need to be elucidated. Although 
to date we have not extensively characterized the ECM 
derived from Thy-1(+) lung fibroblasts cultured in vitro, 
it is plausible to infer that it is similar to the lung ECM in 
young mice and our experimental findings provide a po- 
tential mechanism to explain why young mice do not 
develop the degree lung fibrosis in response to bleomy- 
cin as do older mice.  
In summary, we found that the senescent mouse lung 
recruits and retains more fibrocytes than the young mouse 
lung in response to bleomycin-induced lung injury. We 
speculate that this is in part due to the age-related change 
in lung fibroblast phenotype (i.e. loss of Thy-1 expression) 
and the pro-fibrotic extracellular matrix these senescent 
fibroblasts produce. Following lung injury, this aberrant 
matrix can influence both residential lung fibroblast be- 
havior and the recruitment of fibrocytes that, under the 
additional influence of pro-fibrotic cytokines such as  
TGFβ1, can undergo myofibroblast transdifferentiation 
via activation of the Akt pathway and promote lung fi- 
brosis. In contrast, the “healthy” extracellular matrix in 
the lung that is deposited earlier in life appears to be 
generated primarily by Thy-1(+) lung fibroblasts and ac- 
tually promotes fibrocyte apoptosis, thereby limiting the 
fibrotic response following lung injury. Future studies will 
be necessary to further our understanding of the mechan- 
isms by which fibrocytes interact with the extracellular 
matrix in the lung, including whether these interactions 
are through integrin receptors and/or cross talk between 
integrin receptors and TGFβ1 receptors. Alternatively, the 
lung ECM could influence the responses of fibrocytes via 
mechanotransduction mechanisms that depend on its rela- 
tive structure and/or stiffness that may change with aging. 
Understanding these mechanisms will be critical in our 
quest to identify treatments that can slow or even arrest 
the progression of lung fibrosis. 
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